NUMAFERM
Latest round
- Seed
Last raised
- Sep 2017
Total raised
- Undisclosed
Investors
- 3
About NUMAFERM
Founded in 2017 in Dusseldorf, Germany, Numaferm GmbH specializes in creating high-diversity phage display libraries for applications in pharmaceuticals, agriculture, and aquaculture. Philipp Buerling is the founder, with Christian Schwarz serving as CEO.NUMAFERM GmbH specializes in the production of peptides, pepteins, and proteins through its innovative platforms, namely Numascreen™ and Numatech™. The core offering encompasses high-diversity phage display libraries that exceed 1 billion peptides, facilitating the discovery and optimization of high-affinity binders tailored for various applications.Numaferm generates revenue through structured partnerships and commercial agreements, particularly in the pharmaceutical and agricultural sectors. Their business model includes B2B contracts for lead discovery services and peptide production, often involving fixed pricing for specific projects or milestone-based payments.Numaferm plans to introduce new products in the coming years, expanding its offerings within the peptide and protein markets. The company aims to penetrate new geographical regions, focusing on growth in Asia and South America by 2025.
Who invested in NUMAFERM
3 investors across 1 round
See all investors in NUMAFERM
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Sep 18, 2017
Amount
Undisclosed
Investors
Questions about NUMAFERM
Who invested in NUMAFERM?
NUMAFERM has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has NUMAFERM raised?
NUMAFERM has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did NUMAFERM last raise money?
NUMAFERM's most recent round on record is a Seed, in Sep 2017.
What does NUMAFERM do?
Founded in 2017 in Dusseldorf, Germany, Numaferm GmbH specializes in creating high-diversity phage display libraries for applications in pharmaceuticals, agriculture, and aquaculture.
Where is NUMAFERM headquartered?
NUMAFERM is headquartered in Dusseldorf, Germany.
Which VCs invest in companies like NUMAFERM?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at NUMAFERM's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like NUMAFERM? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.